Twitter Beğeni Hilesi

Looking for the latest on TNBC immunotherapy? Tune in on Sept 21st at 4 PM EDT for a live stream featuring Margaret Gatti-Mays MD, MPH. Topics include new trials, biomarkers, and more. Margaret Gatti-Mays MD MPH FACP 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 Yan Leyfman, MD MedNewsWeek #Keynote Register now: ow.ly/BpbU50TraUQ

Happening today!

Don't miss out! If you didn't get a chance to see Dr. Jasmine Zain's presentation on ''Challenges With CAR T-Cell Therapies in T-Cell Lymphomas." Watch it now via the link below:- onclive.com/view/challenge…

ICYMI: Register here to listen back to this #MedNewsWeek live stream on immunotherapy options for TNBC with expert Margaret Gatti-Mays MD, MPH. Margaret Gatti-Mays MD MPH FACP 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 Yan Leyfman, MD #bcsm #Keynote Register now: onclive.com/mednews/immuno…

Don't miss this exciting presentation from Global Leader & Keynote Speaker, Dr. Gatti-Mays of Ohio State as she discusses immunotherapy for TNBC on MedNews Week Conference in partnership with OncLive.com

🌟 Truly honored to have had the opportunity to speak with Dr. Jasmine Zain and interview her on her groundbreaking research on "Challenges With CAR T-Cell Therapies in T-Cell Lymphomas!" 🎓✨ 🔗 onclive.com/view/challenge…

💉💉Missed our live session on CAR T-cell therapies in T-cell lymphomas? Don't worry! Catch up on groundbreaking insights from Dr. Jasmine Zain and other leading experts as they tackled the biggest challenges in this evolving field. ⭐️ link 🔗-onclive.com/view/challenge…

Calling all Hem/Onc Fellows! Your exclusive community is here! 💡Showcase your research 🔥Debate hot topics 🤝Build a career-launching network Join the Fellows Forum—your launchpad to lead in oncology! oncfellows.com #HemOncFellows #Oncology #FellowsForum

Chandler Park, MD, FACP, and Yan Leyfman, MD, discuss the goal of providing educational oncology content globally to oncologists via MedNews Week. 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 Norton Healthcare Yan Leyfman, MD MedNewsWeek #oncology #MedEd onclive.com/view/park-and-…

⏰ 2 Weeks Until #llmcongress2024 Begins. ⏰ The Lymphoma, Leukemia & Myeloma Congress is fast approaching. With the rise in blood cancer diagnoses, our mission to combat these challenges has never been more crucial. For 24 years, The Lymphoma, Leukemia & Myeloma Congress has

A background into the start of MedNewsWeek highlighting our inspiration, passions, and future goals. Thank you to OncLive.com and the great partnership that we have to take our mission to the next frontier.

What sets MedNewsWeek apart? What are some exciting future initiatives? Check out the latest feature for an exclusive behind-the-scenes look at the future of MedNewsWeek & the impact we're aiming to make with our partner-- OncLive.com! onclive.com/view/park-and-…

Happening NOW! Dive into the realm of AML and its treatment with none other than Justin Kaner, who is the forefront of AML research. Join us as Dr. Kaner talks about “Menin Inhibitors for AML” a topic that's reshaping our currently knowledge in #Hematology and #Oncology

Event link: onclive.com/view/menin-inh… Join us TODAY and be a part of this amazing community pushing the boundaries of our knowledge in oncology!

Chandler Park, MD, FACP, and Yan Leyfman, MD, explained the goal of MedNews Week and highlighted why connecting oncologists from around the globe is vital to advancing care for patients. 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 Norton Healthcare Yan Leyfman, MD MedNewsWeek #oncology #MedEd onclive.com/view/park-and-…

Catch the latest Roundtable Discussion as we host Global Leader & Keynote Speaker, Dr. Justin Kaner of Weill Cornell as he discusses the latest advances surrounding menin inhibitors in AML on MedNewsWeek in partnership with OncLive.com. Presentation: onclive.com/view/menin-inh…

Tune in to the presentation: onclive.com/view/menin-inh…

💡 What Does the Future Hold for #AML Treatment? 💡 We often hear about #breakthroughs in #cancer research, but how often do we get the opportunity to learn directly from those pushing the boundaries? ‼️LIVE NOW‼️ OncLive.com MedNewsWeek

A heartfelt thank you to Justin Kaner from Weill Cornell Medicine for joining us at MedNewsWeek to discuss “Menin Inhibitors for AML: A Roundtable on the Latest Advances.” It has been a highly insightful Keynote and we look forward to the upcoming advancements in the field!

⭐️Join Yousef Zakharia and I w/stellar faculty, urologists, and oncologists in Cedar Rapids, Iowa this Thursday for 2024 ESMO - Eur. Oncology & ASCO updates in GU cancer for OncLive.com SOSS. Click here👉 event.onclive.com/event/e13790dd… Bilal G Rahim @uiowa_urology Urology Center of Iowa Iowa Cancer Specialists, P.C.